This book investigates the complex pathogenesis of malignant mesothelioma and explores current diagnostic methods and emerging translational therapies. It is authored by Harvey I. Pass, a recognized expert in the field, and aims to provide a comprehensive overview for researchers and clinicians. The work synthesizes current knowledge on the molecular mechanisms driving mesothelioma development, details the challenges and advancements in its diagnosis, and critically examines the landscape of therapeutic strategies, including novel drug development and clinical trial approaches.

This text is positioned as a specialized reference for professionals engaged with malignant mesothelioma. Its focus on pathogenesis, diagnosis, and translational therapies suggests a dense, technical work intended for oncologists, pathologists, researchers, and clinical trial investigators. The subject matter indicates a thorough review of scientific literature and clinical data, likely appealing to those seeking detailed, up-to-date information on this challenging disease.